LSR-3000
LSR-3000 is a non-selective serotonin receptor agonist and psychoplastogen of the tryptamine family which is under development for the treatment of neurological disorders.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
LSR-3000 is a non-selective serotonin receptor agonist and psychoplastogen of the tryptamine family which is under development for the treatment of neurological disorders. The drug is taken by mouth. It is under development by Lusaris Therapeutics.
As of November 2022, LSR-3000 is in the research or discovery stage of development. Its chemical structure does not yet appear to have been disclosed.
See also
List of investigational hallucinogens and entactogens
Text derived from https://en.wikipedia.org/w/index.php?oldid=1329123268 under CC BY-SA 4.0; modifications have been made.